CT
RMD icon

Colonial Trust’s ResMed RMD Stock Holding History

Colonial Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$449 – 1177
2026
Q1 		$449 Hold
2
– – ﹤0.01% 1103
2025
Q4 		$482 Sell
2
-3
-60% -$767 ﹤0.01% 1058
2025
Q3 		$1.37K Buy
5
+3
+150% +$819 ﹤0.01% 1017
2025
Q2 		$516 Sell
2
-3
-60% -$716 ﹤0.01% 1056
2025
Q1 		$1.1K Sell
5
-122
-96% -$28.5K ﹤0.01% 1010
2024
Q4 		$29K Buy
127
+125
+6,250% +$30.1K ﹤0.01% 700
2024
Q3 		$478 Buy
+2
New +$447 ﹤0.01% 1053

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Colonial Trust's RMD Position: Q2 2026 in Review

Colonial Trust sold out of ResMed (RMD) in Q2 2026, closing a stake of 2 shares — an estimated $449 sold.

Colonial Trust first reported a position in RMD in Q3 2024 and held it in 7 quarters. The position peaked at $29K in Q4 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Colonial Trust reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Colonial Trust sold 2 ResMed shares in Q2 2026, an estimated $449.
  • Colonial Trust first reported a position in ResMed in Q3 2024 and held it in 7 quarters.
  • Colonial Trust's ResMed position peaked at $29K in Q4 2024.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.